Toggle Offcanvas
...
 
Brinzolamide Tenders

Brinzolamide Tenders

View Brinzolamide tenders, RFPs and contracts. Bid on readily available Brinzolamide tenders with the best and most comprehensive tendering platform, since 2002.

Bidding for Brinzolamide tenders is extremely lucrative for companies of all sizes. Tendering authorities and private companies release thousands of contracts worth millions for procurement of Brinzolamide.

Global Tenders stands out as the largest platform dedicated to pharmaceutical tenders and government contracts. Boasting over 20 years of experience in the tender business, GlobalTenders offers the most extensive and reliable Tenders/RFPs/Contracts Database available. The platform aggregates contracts from both public and private sources, connecting with a vast network of over half a million buyers. Employing advanced artificial intelligence, our meticulous process involves gathering information from over a hundred thousand sources. The data is then intelligently categorized into thousands of subcategories for easy filtering and presenting it in a user-friendly format for quick comprehension.

In addition to tender information, we offer in-depth Brinzolamide market analysis, bid consultancy services, and insights into top bidders and winners.

Sign up now to get instant access to unlimited Brinzolamide tenders, advanced search filters, market analysis, industry trends, tender training and 24/7 customer support.

143 Live Notices for Brinzolamide Tenders

Showing 1 to 20

Subject: Electronic Auction - Hiring Of A Specialized Company For The Installment Purchase Of Specialized Judicial Medicines To Meet The Needs Of The Health Department Of The Municipality Of Cajazeiras-Pb.
country Brazil
posting date30 Jan 2025
deadline13 Feb 2025
Subject: Electronic Auction - Rp Standardized Medicines Iii
country Brazil
posting date30 Jan 2025
deadline13 Feb 2025
Subject: Electronic Auction - Acquisition Of Medicines To Meet The Specialized Component Of Pharmaceutical Assistance (Ceaf), A Strategy For Access To Medicines Within The Scope Of The Sus, Characterized By The Search For Guaranteeing The Integrality Of Drug Treatment, At An Outpatient Level, Whose Lines Of Care Are Defined In Published Clinical Protocols And Therapeutic Guidelines (Pcdt), Under The Terms Below, According To The Conditions And Requirements Established In This Instrument.
country Brazil
posting date30 Jan 2025
deadline13 Feb 2025
Conclusion Of A Non-Exclusive Discount Agreement According To Section 130A Paragraph 8 Sgb V For Medicinal Products Containing The Active Ingredient Combination Of Brinzolamide And Timolol (Atc: S01Ed67).
country Germany
posting date24 Jan 2025
deadline28 Dec 2026
Medicines Containing The Active Ingredient Combination Brinzolamide And Brimonidine (Atc: S01Ec24)
country Germany
posting date21 Jan 2025
deadline31 Dec 2026
Conclusion Of A Non-Exclusive Discount Agreement According To Section 130A Paragraph 8 Sgb V For Medicinal Products Containing The Active Ingredient Combination Of Brinzolamide And Timolol (Atc: S01Ed67).
country Germany
posting date09 Jan 2025
deadline28 Dec 2026
SUPPLY OF AEROCHAMBER SPACER, WITH MASK ADULT&TOBRADEX EYE DROPS 5ML&CARBACHOLE INTRA OCULAR SOLUTION&BRINZOLAMIDE EYE DROPS 1% 5 ML&BRINZOLAMIDE EYE DROPS 1% 5 MLTROPICAMIDE MINIMS 0.5% 0.5ML&EMEDASTINE 0.05% EYE DROPS , 5 ML&OXYBUPROCAINE EYE DROPS 0.4% 0.5ML MINIMS&SYSTANE EYE DROPSetc.
country Oman
posting date02 Jan 2025
deadline10 Feb 2025
Conclusion Of Non-Exclusive Discount Agreements According To §130A Para.8 Sgb V For Various Active Ingredients/Combinations With The Possibility Of Conclusion At Any Time Within The Framework Of The So-Called Open House Procedure
country Germany
posting date05 Dec 2024
deadline05 Dec 2026
Conclusion Of Non-Exclusive Discount Agreements According To §130A Para.8 Sgb V For Various Active Ingredients/Combinations With The Possibility Of Conclusion At Any Time Within The Framework Of The So-Called Open House Procedure
country Germany
posting date26 Nov 2024
deadline05 Dec 2026
Open House Discount Agreements 2024-13
country Germany
posting date15 Nov 2024
deadline31 Dec 2026
Medicines Containing The Active Ingredient Combination Brinzolamide And Timolol (Atc: S01Ed67)
country Germany
posting date13 Nov 2024
deadline31 Oct 2026
Conclusion Of A Non-Exclusive Drug Discount Agreement Pursuant To Section 130A Paragraph 8 Of The Social Code Book V By Means Of An Open-House Model For The Active Ingredient Brinzolamide/Timolol (Official Atc Code: S01Ed67)
country Germany
posting date11 Nov 2024
deadline31 Dec 2026
Conclusion Of A Non-Exclusive Drug Discount Agreement Pursuant To Section 130A Paragraph 8 Of The Social Code Book V By Means Of An Open-House Model For The Active Ingredient Brinzolamide/Timolol (Official Atc Code: S01Ed67)
country Germany
posting date11 Nov 2024
deadline31 Dec 2026
Conclusion Of A Non-Exclusive Drug Discount Agreement Pursuant To Section 130A Paragraph 8 Of The Social Code Book V By Means Of An Open-House Model For The Active Ingredient Brinzolamide/Timolol (Official Atc Code: S01Ed67)
country Germany
posting date11 Nov 2024
deadline31 Dec 2026
Conclusion Of A Non-Exclusive Discount Agreement According To Section 130A Paragraph 8 Sgb V For Medicinal Products Containing The Active Ingredient Combination Of Brinzolamide And Brimonidine (Atc Code: S01Ec24).
country Germany
posting date30 Oct 2024
deadline27 Oct 2026
Conclusion Of Non-Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8/130C Paragraph 1 Sgb V For Medicinal Products Containing The Active Ingredients Brinzolamide And Brimonidine (S01Ec24) Within The Framework Of A So-Called Open-House Model.
country Germany
posting date12 Oct 2024
deadline30 Sep 2026
Conclusion Of Non-Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8/130C Paragraph 1 Sgb V For Medicinal Products Containing The Active Ingredients Brinzolamide And Brimonidine (S01Ec24) Within The Framework Of A So-Called Open-House Model.
country Germany
posting date12 Oct 2024
deadline30 Sep 2026
Conclusion Of A Non-Exclusive Discount Agreement Pursuant To Section 130A Paragraph 8 Sgb V For The Active Ingredient Timolol + Brinzolamide, Atc S01Ed67 (Obg) For The Period 01.11.2024 - 31.10.2026
country Germany
posting date17 Sep 2024
deadline05 Sep 2026
Conclusion Of A Non-Exclusive Discount Agreement Pursuant To Section 130A Paragraph 8 Sgb V For The Active Ingredient Timolol + Brinzolamide, Atc S01Ed67 (Obg) For The Period 01.11.2024 - 31.10.2026
country Germany
posting date17 Sep 2024
deadline05 Sep 2026
Pharmaceutical Discount Agreements From 1 November 2024 For Various Active Ingredients As Part Of An Open House Procedure
country Germany
posting date09 Sep 2024
deadline01 Sep 2026

Share Share this page